MDIs, DPIs, SMIs and Nebulizers
APSD of Inhaler Devices
Aerodynamic Particle Size Distribution (APSD) testing for inhaler devices, such as metered-dose inhalers (MDIs) and dry powder inhalers (DPIs), is crucial for determining how particles are dispersed and deposited in the respiratory tract. The size of the particles delivered by these devices influences where the drug is deposited—whether in the upper airways, lungs, or deep alveolar regions. APSD testing ensures that inhaler devices produce particles of the correct size range for optimal therapeutic effect, improving drug absorption and patient outcomes. This testing is typically conducted using cascade impactors or similar equipment, under conditions that replicate real-world use.